Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil
Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/1478-7547-11-25
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC